Veracyte, Inc. (VCYT) News
Filter VCYT News Items
VCYT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VCYT News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest VCYT News From Around the Web
Below are the latest news stories about VERACYTE INC that investors may wish to consider to help them evaluate VCYT as an investment opportunity.
GMED Stock Rides on NuVasive Synergy Benefits Amid Macro IssuesGlobus Medical is seeing notable gains across its product portfolio in expandables, biologics, MIS screws, 3D printed implants and cervical offerings. |
Veracyte, Inc. (NASDAQ:VCYT) Has Found A Path To ProfitabilityVeracyte, Inc. ( NASDAQ:VCYT ) is possibly approaching a major achievement in its business, so we would like to shine... |
The Zacks Rank Explained: How to Find Strong Buy Medical StocksThe Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage. |
Veracyte Gains 44% in a Year: What's Driving the Stock?VCYT is gaining shares due to the strength of its Afirma and Decipher tests. |
Macroeconomic Woes, FX Headwind Drag NEOG Stock DownNEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products. |
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?PAHC shares gain owing to the remarkable performance of the Animal Health business and potential in the emerging markets. |
Should You Retain Labcorp Stock in Your Portfolio Right Now?Investors are increasingly optimistic about LH due to its focus on high-growth areas and strategic partnerships. |
Here's Why VCYT Stock Could be a Great Addition to Your Portfolio NowVeracyte's progress with key drivers and the strength in its diagnostics tests bring optimism to investors. |
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott LaboratoriesVeracyte, Omnicell, Masimo and Abbott Laboratories are included in this Analyst Blog. |
Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks?The Healthcare sector sees volume growth and improved occupancy while battling rising medical costs and regulatory uncertainty. |